Answers are grounded in this paper and cite their sources.
Azathioprine (AZA) is a commonly used immunosuppressant in organ-transplantation recipients. AZA is rapidly converted to 6-mercaptopurine and subsequently converted to 6-thioguanine nucleotides (6-TGN) by way of hypoxanthineguanine phosphoribosyltransferase to exert its immunosuppressant activity. Alternatively, AZA is metabolized to inactive metabolites, 6-methylmercaptopurine by thiopurine S-methyltransferase (TPMT) and 6-thiouric acid by xanthine oxidase (XO). Interindividual variation in TPMT activity is significant, largely because of genetic polymorphism. Approximately 1 in 300 whites are TPMT deficient and exhibit low activity, and about 10% have an “intermediate” phenotype (1). To date, more than 10 allelic variants of TPMT have been identified. TPMT*3A and TPMT*3C are the most common mutant alleles associated with low TPMT activity in whites and Asians, respectively (1). Because of the absence of XO enzyme in hematopoietic tissues, TPMT appears to be the key enzyme responsible for inactivation of AZA in these tissues. Patients with TPMT deficiency rapidly accumulate high concentrations of 6-TGN, resulting in potentially fatal myelotoxicity (1). Here, we report on a 38-year-old man with chronic renal failure who underwent allogenic renal transplantation. Immunosuppressant therapy posttransplantation consisted of cyclosporine and prednisolone. AZA (1.5 mg/kg per day) was added at day 2 after surgery. The immediate postoperative outcome was uncomplicated. White blood counts (WBC) and platelet counts (PC) were stable during the first 12 days after surgery. At day 14, WBC and PC decreased from 10.4×103/mm3 and 222×103/mm3 to 4.2×103/mm3 and 131×103/mm3, respectively (Fig. 1). At day 16 after surgery, WBC and PC were decreased to 0.9×103/mm3 and 68×103/mm3, respectively. AZA was then discontinued and granulocyte colonystimulating factor was administered to the patient. From day 16 to 24, the patient experienced fever, diarrhea, and upper gastrointestinal bleeding. WBC and PC reached a nadir of 1×102/mm3 and 12×103/mm3, respectively, at day 20. He developed pneumonia (from Xanthomonas maltophilia and Pseudomonas aeruginosa) and peritonitis (from Xanthomonas maltophilia and Candida albicans). Antibiotics, fresh frozen plasma, platelet concentration, and packed red cells were given during this period. The patient finally died from cardiopulmonary arrest caused by severe hypoxia secondary from pulmonary hemorrhage.Figure 1. The patient's white blood count and platelet count after surgery. AZA, azathioprine.Because of the unavailability of a blood sample, the patient's TPMT activity could not be measured. However, we were able to characterize TPMT genotype from gDNA (surplus to histocompatibility test) by polymerase chain reaction-restriction fragment length polymorphism (2). Genotyping revealed that the patient was heterozygous TPMT*1/*3C arising from an A to G transition at nucleotide 719 (leading to substitution of cysteine for tyrosine at residue 240). Severe AZA-induced myelosuppression has been reported in heart- and renal-transplant recipients with very low TPMT activity (3, 4). A recent study of heart-transplant recipients demonstrated that heterozygous TPMT patients were at high risk of AZA-induced myelotoxicity (5). Together with these recent data, our finding suggests that knowledge of patients' TPMT genotype before prescribing AZA may be beneficial in the avoidance of toxicity. Patients with a TPMT mutant allele are at high risk of myelosuppression when prescribed AZA. In such patients, alternative regimens should be considered. Wichittra Tassaneeyakul Somrudee Srimarthpirom Sirirat Reungjui Kanchana Chansung Amornrat Romphruk Wongwiwat Tassaneeyakul 1Department of Pharmacology Khon Kaen University Khon Kaen, Thailand 2Department of Medicine Khon Kaen University Khon Kaen, Thailand 3Blood Transfusion Center, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand 4Department of Toxicology, Faculty of Pharmaceutical Sciences Khon Kaen University Khon Kaen, Thailand
No takes yet. Share an insight, caveat, or question.
Tassaneeyakul et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: